Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleonora Distrutti

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
World Journal of Gastroenterology|February 23, 2016
Gut microbiota role in irritable bowel syndrome: New therapeutic strategiesEleonora Distrutti, Lorenzo Monaldi, Patrizia Ricci, et al.
Expert Opinion on Therapeutic Patents|April 14, 2018
Farnesoid X receptor modulators 2014-present: a patent reviewValentina Sepe, Eleonora Distrutti, Stefano Fiorucci, et al.
Expert Opinion on Therapeutic Patents|July 18, 2015
Farnesoid X receptor modulators (2011 - 2014): a patent reviewValentina Sepe, Eleonora Distrutti, Stefano Fiorucci, et al.
The American Journal of Gastroenterology|December 23, 2003
Rectal function and bowel habit in irritable bowel syndromeEleonora Distrutti, Beatrice Salvioli, Fernando Azpiroz, et al.
Gastroenterology|July 13, 2006
The emerging roles of hydrogen sulfide in the gastrointestinal tract and liverStefano Fiorucci, Eleonora Distrutti, Giuseppe Cirino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2009
The bile acid receptor FXR is a modulator of intestinal innate immunityPiero Vavassori, Andrea Mencarelli, Barbara Renga, et al.
Future Medicinal Chemistry|July 2, 2015
Steroidal scaffolds as FXR and GPBAR1 ligands: from chemistry to therapeutical applicationValentina Sepe, Eleonora Distrutti, Vittorio Limongelli, et al.
Trends in Molecular Medicine|June 26, 2007
Targeting farnesoid X receptor for liver and metabolic disordersStefano Fiorucci, Gianni Rizzo, Annibale Donini, et al.
World Journal of Gastroenterology|May 7, 2009
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculationBarbara Renga, Andrea Mencarelli, Marco Migliorati, et al.
Plos One|May 22, 2013
Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndromeEleonora Distrutti, Sabrina Cipriani, Andrea Mencarelli, et al.
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
World Journal of Gastroenterology|February 23, 2016
Gut microbiota role in irritable bowel syndrome: New therapeutic strategiesEleonora Distrutti, Lorenzo Monaldi, Patrizia Ricci, et al.
Expert Opinion on Therapeutic Patents|April 14, 2018
Farnesoid X receptor modulators 2014-present: a patent reviewValentina Sepe, Eleonora Distrutti, Stefano Fiorucci, et al.
Expert Opinion on Therapeutic Patents|July 18, 2015
Farnesoid X receptor modulators (2011 - 2014): a patent reviewValentina Sepe, Eleonora Distrutti, Stefano Fiorucci, et al.
The American Journal of Gastroenterology|December 23, 2003
Rectal function and bowel habit in irritable bowel syndromeEleonora Distrutti, Beatrice Salvioli, Fernando Azpiroz, et al.
Gastroenterology|July 13, 2006
The emerging roles of hydrogen sulfide in the gastrointestinal tract and liverStefano Fiorucci, Eleonora Distrutti, Giuseppe Cirino, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2009
The bile acid receptor FXR is a modulator of intestinal innate immunityPiero Vavassori, Andrea Mencarelli, Barbara Renga, et al.
Future Medicinal Chemistry|July 2, 2015
Steroidal scaffolds as FXR and GPBAR1 ligands: from chemistry to therapeutical applicationValentina Sepe, Eleonora Distrutti, Vittorio Limongelli, et al.
Trends in Molecular Medicine|June 26, 2007
Targeting farnesoid X receptor for liver and metabolic disordersStefano Fiorucci, Gianni Rizzo, Annibale Donini, et al.
World Journal of Gastroenterology|May 7, 2009
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculationBarbara Renga, Andrea Mencarelli, Marco Migliorati, et al.
Plos One|May 22, 2013
Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndromeEleonora Distrutti, Sabrina Cipriani, Andrea Mencarelli, et al.
Pageof 15